Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Hemiplegic Migraine Market Research Report by Type (Familial, Sporadic), by Treatment (Acute, Preventive), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), by End-user (Hospitals & Clinics, Diagnostic Centers, Others), and Region - Forecast till 2030


ID: MRFR/HC/5250-HCR | 110 Pages | Author: Kinjoll Dey| May 2024

Hemiplegic Migraine Market Overview:


The Hemiplegic Migraine Market is expected to reach USD 1.69 Billion by 2030 at 2.90% CAGR during the forecast period 2022-2030. Hemiplegic migraine, although a rare type of migraine its symptoms are almost same as other migraines. ¬†Intense and throbbing pain, nausea, and sensitivity to light and sound are some of the symptoms caused by hemiplegic migraine. ‚ÄúHemiplegia‚ÄĚ means paralysis and people suffering from it literally feel temporary symptoms of paralysis such as temporary weakness, numbness and tingling, and paralysis on one side of the body which start before the headache.


Although the hemiplegic migraine is considered as a rare disorder affecting a small number of people, over the past few years, the prevalence of hemiplegic migraine has been increasing. Out of the two types of hemiplegic migraine, familial hemiplegic migraine (FHM) is a hereditary condition that affects at least two close relatives in the same family.  


Whereas, the other type, sporadic hemiplegic migraine (SHM) can affect anyone even those who don’t have any family history of the condition. Factors such as changing lifestyle, environmental changes, pollutions, etc. are causes behind the occurrence of SHM. As a result, sporadic hemiplegic migraine is more prevalent than FHM.


However, there are a number of treatment methods available to treat both the types of hemiplegic migraines owing to the technological advancements that happened in the field of medical science in the recent years. Growing prevalence and the availability of treatments are the two key driving forces behind the hemiplegic migraine market growth of hemiplegic migraines.


Considering all these factors, the hemiplegic migraine market is expected to reach approximately 1008 MN USD by the end of 2023, growing at a CAGR of approximately 3.3% during the forecast period (2022-2030). In 2017, the hemiplegic migraine market had valued at USD 830 Million.


Segments


The hemiplegic migraine market has been segmented on the basis of type, treatment, preventive treatment, distribution channel, end-user, and region. By type, the hemiplegic migraine market is segmented into familial hemiplegic migraine and sporadic hemiplegic migraine. By end-user, the hemiplegic migraine market is segmented into hospitals & clinics, diagnostic centers, and others.


By treatment, the hemiplegic migraine market is segmented into acute treatment, triptans, ergotamines, nsaids, antiemetics, narcotic analgesics, and others. By preventive treatment, the hemiplegic migraine market is segmented into antidepressants, botox injections, and others. By distribution channel, the hemiplegic migraine market is segmented into retail pharmacies, hospital pharmacies, online pharmacies, and others. By region, the hemiplegic migraine market is segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa.


Regional analysis


The Americas accounts for the leading market due to the higher health care expenditures. The fastest uptake of new technologies in the growing healthcare sector is a major driving force driving the hemiplegic migraine market. The presence of well-established market players is fuelling the market.


The market in the European region stands at the second position in terms of the market size owing to the well-established healthcare sector. Also, high per capita healthcare expenditures play a vital role in the hemiplegic migraine market growth.


Whereas, the Asia Pacific region is expected to grow rapidly due to the emerging economies such as China and India.


In Gulf nations, particularly, Saudi Arabia and UAE drive the Middle Eastern & African market. The African region is estimated to witness moderate growth owing to poor economic & political conditions and inadequate healthcare facilities.


Key Players


Some of the market leaders profiled in the report are Abbott Laboratories, Allergan Plc., AstraZeneca, Eisai Co., Ltd., Endo International Plc., GlaxoSmithKline Plc., Impax Laboratories, Eli Lily and Company, Johnson & Johnson, and Merck & Co.


Research Methodology


The research report - Hemiplegic Migraine Market by Market Research Future comprises an in-depth primary research and the detailed analysis of qualitative as well as quantitative aspects of various industry experts. The detailed market analysis gives a clear picture of the current market scenarios including past and future market size in terms of value as well as volume alongside the technological advancement, macroeconomy, and governing factors of the market. The report provides detailed information and strategies of topnotch players in the market while providing a broad study of the market and its various segments in the outlined regions.


Hemiplegic Migraine Market by Type



  • Familial Hemiplegic Migraine

  • Sporadic Hemiplegic Migraine¬†


Hemiplegic Migraine Market by Treatment




  • Acute treatment

  • Triptans

  • Ergotamines

  • NSAIDS

  • Antiemetics

  • Narcotic Analgesics

  • Others


Hemiplegic Migraine Market by End-user



  • Hospitals & Clinics

  • Diagnostic Centers

  • Others¬†


Hemiplegic Migraine Market by Preventive Treatment



  • Antidepressants

  • Botox Injections

  • Others


Hemiplegic Migraine Market by Distribution Channel



  • Retail Pharmacies

  • Hospital Pharmacies

  • Online Pharmacies¬†


Region



  • Americas

    • The U.S.

    • Canada




    • North America

    • South America




  • Europe

    • France

    • The U.K.

    • Germany

    • Italy

    • Spain

    • Rest of Western Europe




    • Western Europe

    • Eastern Europe




  • Asia Pacific


    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia Pacific


Report Attribute/Metric Details
  Market Size 1.69 Billion
  CAGR   2.90%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2019
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Basis of type, Treatment, Preventive Treatment, Distribution channel, End-user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Abbott Laboratories, Allergan Plc., AstraZeneca, Eisai Co., Ltd., Endo International Plc., GlaxoSmithKline Plc., Impax Laboratories, Eli Lily and Company, Johnson & Johnson, and Merck & Co
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers ·  Growing prevalence·  The availability of treatments
 

Frequently Asked Questions (FAQ) :

Hemiplegic migraine market projected to grow at a 2.90% CAGR between 2022-2030.

Hemiplegic migraine market is predicted to touch USD 1.69 Billion by 2030.

The Americas is expected to lead the hemiplegic migraine market.

Environmental changes and rising prevalence of hemiplegic migraine are the key factors driving the hemiplegic migraine market.

Side effects may limit the hemiplegic migraine market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.